We have located links that may give you full text access.
Differential contribution for ERK1 and ERK2 kinases in BRAF V600E -triggered phenotypes in adult mouse models.
Cell Death and Differentiation 2024 May 3
The BRAF gene is mutated in a plethora of human cancers. The majority of such molecular lesions result in the expression of a constitutively active BRAF variant (BRAFV600E ) which continuously bolsters cell proliferation. Although we recently addressed the early effects triggered by BRAFV600E -activation, the specific contribution of ERK1 and ERK2 in BRAFV600E -driven responses in vivo has never been explored. Here we describe the first murine model suitable for genetically dissecting the ERK1/ERK2 impact in multiple phenotypes induced by ubiquitous BRAFV600E -expression. We unveil that ERK1 is dispensable for BRAFV600E -dependent lifespan shortening and for BRAFV600E -driven tumor growth. We show that BRAFV600E -expression provokes an ERK1-independent lymphocyte depletion which does not rely on p21CIP1 -induced cell cycle arrest and is unresponsive to ERK-chemical inhibition. Moreover, we also reveal that ERK1 is dispensable for BRAFV600E -triggered cytotoxicity in lungs and that ERK-chemical inhibition abrogates some of these detrimental effects, such as DNA damage, in Club cells but not in pulmonary lymphocytes. Our data suggest that ERK1/ERK2 contribution to BRAFV600E -driven phenotypes is dynamic and varies dependently on cell type, the biological function, and the level of ERK-pathway activation. Our findings also provide useful insights into the comprehension of BRAFV600E -driven malignancies pathophysiology as well as the consequences in vivo of novel ERK pathway-targeted anti-cancer therapies.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app